Abstract
Probiotics are nowadays frequently used by patients with inflammatory bowel disease, however literature data are conflicting related to their importance.
In mild to moderate ulcerative colitis probiotics can be used effectively in induction and maintaining remission, and prevention of pouchitis. As the other side of the shield, there is not sufficient evidence to support the use of probiotics in daily clinical practice in Crohn’s disease.
The aim of the present review is to provide help for clinicians about the probiotic use in patients with inflammatory bowel disease. The comparison of literature data is limited by the large number of probiotic strains, various combined preparations, and different doses applied in the clinical studies. Small number of comparable protocols and lack of standardization encumber the analysis of study results.
Keywords: Probiotics, inflammatory bowel disease.
Current Pharmaceutical Design
Title:Probiotics in the Management of Crohn's disease and Ulcerative Colitis
Volume: 20 Issue: 28
Author(s): Katalin Mullner, Pal Miheller, Laszlo Herszenyi and Zsolt Tulassay
Affiliation:
Keywords: Probiotics, inflammatory bowel disease.
Abstract: Probiotics are nowadays frequently used by patients with inflammatory bowel disease, however literature data are conflicting related to their importance.
In mild to moderate ulcerative colitis probiotics can be used effectively in induction and maintaining remission, and prevention of pouchitis. As the other side of the shield, there is not sufficient evidence to support the use of probiotics in daily clinical practice in Crohn’s disease.
The aim of the present review is to provide help for clinicians about the probiotic use in patients with inflammatory bowel disease. The comparison of literature data is limited by the large number of probiotic strains, various combined preparations, and different doses applied in the clinical studies. Small number of comparable protocols and lack of standardization encumber the analysis of study results.
Export Options
About this article
Cite this article as:
Mullner Katalin, Miheller Pal, Herszenyi Laszlo and Tulassay Zsolt, Probiotics in the Management of Crohn's disease and Ulcerative Colitis, Current Pharmaceutical Design 2014; 20(28) . https://dx.doi.org/10.2174/13816128113196660727
DOI https://dx.doi.org/10.2174/13816128113196660727 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |

- Author Guidelines
- Editorial Policies
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Allegations from Whistleblowers
- Publishing Ethics and Rectitude
- Increase Visibility Of Your Article
- Archiving Policies
- Reviewer Guidelines
- Guest Editor Guidelines
- Board Recruitment Workflow
- Short Guide for New Editors
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
Physiological Basis for Contractile Dysfunction in Heart Failure
Current Pharmaceutical Design Flavonoids on Allergy
Current Pharmaceutical Design Relevance of the Neuropeptide Y System in the Biology of Cancer Progression
Current Topics in Medicinal Chemistry Emerging Therapeutic Strategies for Hepatitis C Virus Infection
Current Molecular Pharmacology Genetics of Interleukin 1 Receptor-Like 1 in Immune and Inflammatory Diseases
Current Genomics An Overview: Current Systemic Therapies for Advanced Non-Small Cell Lung Cancer
Current Respiratory Medicine Reviews Histone Deacetylase Inhibitors: New Hope for Rheumatoid Arthritis?
Current Pharmaceutical Design Chondromodulating Chimeric Prodrugs of Diacetylrhein: Synthesis and Evaluation in Monoiodoacetate-induced Hyperalgesia
Medicinal Chemistry Advances of Paclitaxel Formulations Based on Nanosystem Delivery Technology
Mini-Reviews in Medicinal Chemistry Non-pharmacological Strategies Against Systemic Inflammation: Molecular Basis and Clinical Evidence
Current Pharmaceutical Design Biotechnological Manufacturing Options for Organic Chemistry
Mini-Reviews in Organic Chemistry Patent Selections
Recent Patents on Food, Nutrition & Agriculture Preclinical Evaluation of New Taxoids
Current Pharmaceutical Design A Macro Role for Imprinted Clusters of MicroRNAs in the Brain
MicroRNA The Double Roles of the Prostaglandin E<sub>2</sub> EP2 Receptor in Intracerebral Hemorrhage
Current Drug Targets Epithelial Mesenchymal Transition in Cancer Progression: Prev entive Phytochemicals
Recent Patents on Anti-Cancer Drug Discovery The Central Role of Leukotriene B4 in Epstein Barr Virus Activated Innate Immunity In Vitro
Current Immunology Reviews (Discontinued) Epithelial Cell Signaling in Helicobacter pylori Infection
Current Signal Transduction Therapy Endotoxin Neutralizing Peptides
Current Topics in Medicinal Chemistry The GH/IGF-1 Axis in Chronic Heart Failure
Endocrine, Metabolic & Immune Disorders - Drug Targets